APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbiota Transplantation Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microbiota Transplantation Service Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchMicrobiota Transplantation Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbiota Transplantation Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Microbiota Transplantation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbiota Transplantation Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Microbiota Transplantation Service Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Microbiota Transplantation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microbiota Transplantation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbiota Transplantation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbiota Transplantation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microbiota Transplantation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microbiota Transplantation Service market include Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health, Metabiomics and J-Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microbiota Transplantation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbiota Transplantation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbiota Transplantation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microbiota Transplantation Service market.

Microbiota Transplantation Service Segment by Company

Seres Therapeutics

Finch Therapeutics

OpenBiome

Vedanta Biosciences

MaaT Pharma

BiomX

Entera Health

Metabiomics

J-Pharma

Hangzhou Shengshi Technology

Ruiyi Biotechnology

Jiangsu Junkey Life Technology Development

Hangzhou Yuanxiang Medical Technology

MAUSOAR

Shanghai Chengge Biotechnology

Guangzhou Zhiyi Biotechnology

Shenzhen Unknown Jun Biotechnology

Sichuan Anaerobic Biotechnology

Microbiota Transplantation Service Segment by Type

Traditional Intestinal Transplantation

Oral Capsule Transplantation

Microbiota Transplantation Service Segment by Application

Medical Industry

Health Management Industry

Animal Health Industry

Others

Microbiota Transplantation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microbiota Transplantation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microbiota Transplantation Service key companies, revenue, market share, and recent developments.

3. To split the Microbiota Transplantation Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microbiota Transplantation Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microbiota Transplantation Service significant trends, drivers, influence factors in global and regions.

6. To analyze Microbiota Transplantation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiota Transplantation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbiota Transplantation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiota Transplantation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbiota Transplantation Service industry.

Chapter 3: Detailed analysis of Microbiota Transplantation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microbiota Transplantation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microbiota Transplantation Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microbiota Transplantation Service Industry Trends Table 2. Microbiota Transplantation Service Industry Drivers Table 3. Microbiota Transplantation Service Industry Opportunities and Challenges Table 4. Microbiota Transplantation Service Industry Restraints Table 5. Global Microbiota Transplantation Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microbiota Transplantation Service Revenue Share by Company (2021-2026) Table 7. Global Microbiota Transplantation Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microbiota Transplantation Service Key Company Manufacturing Base & Headquarters Table 9. Global Microbiota Transplantation Service Company, Product Type & Application Table 10. Global Microbiota Transplantation Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microbiota Transplantation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Traditional Intestinal Transplantation Table 15. Significant Companies of Oral Capsule Transplantation Table 16. Global Microbiota Transplantation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Microbiota Transplantation Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Microbiota Transplantation Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Microbiota Transplantation Service Sales Value Share by Type (2021-2026) Table 20. Global Microbiota Transplantation Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Industry Table 22. Significant Companies of Health Management Industry Table 23. Significant Companies of Animal Health Industry Table 24. Significant Companies of Others Table 25. Global Microbiota Transplantation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Microbiota Transplantation Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Microbiota Transplantation Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Microbiota Transplantation Service Sales Value Share by Application (2021-2026) Table 29. Global Microbiota Transplantation Service Sales Value Share by Application (2027-2032) Table 30. Global Microbiota Transplantation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Microbiota Transplantation Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Microbiota Transplantation Service Sales Value Share by Region (2021-2026) Table 33. Global Microbiota Transplantation Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Microbiota Transplantation Service Sales Value Share by Region (2027-2032) Table 35. Global Microbiota Transplantation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Microbiota Transplantation Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Microbiota Transplantation Service Sales Value Market Share by Country (2021-2026) Table 38. Global Microbiota Transplantation Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Microbiota Transplantation Service Sales Value Market Share by Country (2027-2032) Table 40. Seres Therapeutics Company Information Table 41. Seres Therapeutics Business Overview Table 42. Seres Therapeutics Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Seres Therapeutics Microbiota Transplantation Service Product Portfolio Table 44. Seres Therapeutics Recent Development Table 45. Finch Therapeutics Company Information Table 46. Finch Therapeutics Business Overview Table 47. Finch Therapeutics Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Finch Therapeutics Microbiota Transplantation Service Product Portfolio Table 49. Finch Therapeutics Recent Development Table 50. OpenBiome Company Information Table 51. OpenBiome Business Overview Table 52. OpenBiome Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. OpenBiome Microbiota Transplantation Service Product Portfolio Table 54. OpenBiome Recent Development Table 55. Vedanta Biosciences Company Information Table 56. Vedanta Biosciences Business Overview Table 57. Vedanta Biosciences Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Vedanta Biosciences Microbiota Transplantation Service Product Portfolio Table 59. Vedanta Biosciences Recent Development Table 60. MaaT Pharma Company Information Table 61. MaaT Pharma Business Overview Table 62. MaaT Pharma Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MaaT Pharma Microbiota Transplantation Service Product Portfolio Table 64. MaaT Pharma Recent Development Table 65. BiomX Company Information Table 66. BiomX Business Overview Table 67. BiomX Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BiomX Microbiota Transplantation Service Product Portfolio Table 69. BiomX Recent Development Table 70. Entera Health Company Information Table 71. Entera Health Business Overview Table 72. Entera Health Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Entera Health Microbiota Transplantation Service Product Portfolio Table 74. Entera Health Recent Development Table 75. Metabiomics Company Information Table 76. Metabiomics Business Overview Table 77. Metabiomics Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Metabiomics Microbiota Transplantation Service Product Portfolio Table 79. Metabiomics Recent Development Table 80. J-Pharma Company Information Table 81. J-Pharma Business Overview Table 82. J-Pharma Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. J-Pharma Microbiota Transplantation Service Product Portfolio Table 84. J-Pharma Recent Development Table 85. Hangzhou Shengshi Technology Company Information Table 86. Hangzhou Shengshi Technology Business Overview Table 87. Hangzhou Shengshi Technology Microbiota Transplantation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hangzhou Shengshi Technology Microbiota Transplantation Service Product Portfolio Table 89. Hangzhou Shengshi Technology Recent Development Table 90. Ruiyi Biotechnology Company Information Table 91. Ruiyi Biotechnology Business Overview Table 92. Ruiyi Biotechnology Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Ruiyi Biotechnology Microbiota Transplantation Service Product Portfolio Table 94. Ruiyi Biotechnology Recent Development Table 95. Jiangsu Junkey Life Technology Development Company Information Table 96. Jiangsu Junkey Life Technology Development Business Overview Table 97. Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Product Portfolio Table 99. Jiangsu Junkey Life Technology Development Recent Development Table 100. Hangzhou Yuanxiang Medical Technology Company Information Table 101. Hangzhou Yuanxiang Medical Technology Business Overview Table 102. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Product Portfolio Table 104. Hangzhou Yuanxiang Medical Technology Recent Development Table 105. MAUSOAR Company Information Table 106. MAUSOAR Business Overview Table 107. MAUSOAR Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. MAUSOAR Microbiota Transplantation Service Product Portfolio Table 109. MAUSOAR Recent Development Table 110. Shanghai Chengge Biotechnology Company Information Table 111. Shanghai Chengge Biotechnology Business Overview Table 112. Shanghai Chengge Biotechnology Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Shanghai Chengge Biotechnology Microbiota Transplantation Service Product Portfolio Table 114. Shanghai Chengge Biotechnology Recent Development Table 115. Guangzhou Zhiyi Biotechnology Company Information Table 116. Guangzhou Zhiyi Biotechnology Business Overview Table 117. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Product Portfolio Table 119. Guangzhou Zhiyi Biotechnology Recent Development Table 120. Shenzhen Unknown Jun Biotechnology Company Information Table 121. Shenzhen Unknown Jun Biotechnology Business Overview Table 122. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Product Portfolio Table 124. Shenzhen Unknown Jun Biotechnology Recent Development Table 125. Sichuan Anaerobic Biotechnology Company Information Table 126. Sichuan Anaerobic Biotechnology Business Overview Table 127. Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Product Portfolio Table 129. Sichuan Anaerobic Biotechnology Recent Development Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Microbiota Transplantation Service Product Image Figure 2. Global Microbiota Transplantation Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbiota Transplantation Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbiota Transplantation Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Traditional Intestinal Transplantation Image Figure 8. Oral Capsule Transplantation Image Figure 9. Global Microbiota Transplantation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Microbiota Transplantation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Microbiota Transplantation Service Sales Value Share by Type (2021-2032) Figure 12. Medical Industry Image Figure 13. Health Management Industry Image Figure 14. Animal Health Industry Image Figure 15. Others Image Figure 16. Global Microbiota Transplantation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Microbiota Transplantation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Microbiota Transplantation Service Sales Value Share by Application (2021-2032) Figure 19. Global Microbiota Transplantation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Microbiota Transplantation Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Microbiota Transplantation Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Microbiota Transplantation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Microbiota Transplantation Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Microbiota Transplantation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Microbiota Transplantation Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Microbiota Transplantation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Microbiota Transplantation Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Microbiota Transplantation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Microbiota Transplantation Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Microbiota Transplantation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Microbiota Transplantation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Intestinal Transplantation
  • Oral Capsule Transplantation
Applications
  • Medical Industry
  • Health Management Industry
  • Animal Health Industry
  • Others
Companies covered
  • Seres Therapeutics
  • Finch Therapeutics
  • OpenBiome
  • Vedanta Biosciences
  • MaaT Pharma
  • BiomX
  • Entera Health
  • Metabiomics
  • J-Pharma
  • Hangzhou Shengshi Technology
  • Ruiyi Biotechnology
  • Jiangsu Junkey Life Technology Development
  • Hangzhou Yuanxiang Medical Technology
  • MAUSOAR
  • Shanghai Chengge Biotechnology
  • Guangzhou Zhiyi Biotechnology
  • Shenzhen Unknown Jun Biotechnology
  • Sichuan Anaerobic Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbiota Transplantation Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbiota Transplantation Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microbiota Transplantation Service Market Dynamics
  1. 2.1 Microbiota Transplantation Service Industry Trends
  2. 2.2 Microbiota Transplantation Service Industry Drivers
  3. 2.3 Microbiota Transplantation Service Industry Opportunities and Challenges
  4. 2.4 Microbiota Transplantation Service Industry Restraints
3 Microbiota Transplantation Service Market by Company
  1. 3.1 Global Microbiota Transplantation Service Company Revenue Ranking in 2025
  2. 3.2 Global Microbiota Transplantation Service Revenue by Company (2021-2026)
  3. 3.3 Global Microbiota Transplantation Service Company Ranking (2024-2026)
  4. 3.4 Global Microbiota Transplantation Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Microbiota Transplantation Service Company Product Type and Application
  6. 3.6 Global Microbiota Transplantation Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microbiota Transplantation Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microbiota Transplantation Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microbiota Transplantation Service Market by Type
  1. 4.1 Microbiota Transplantation Service Type Introduction
  2. 4.1.1 Traditional Intestinal Transplantation
  3. 4.1.2 Oral Capsule Transplantation
  4. 4.2 Global Microbiota Transplantation Service Sales Value by Type
  5. 4.2.1 Global Microbiota Transplantation Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Microbiota Transplantation Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Microbiota Transplantation Service Sales Value Share by Type (2021-2032)
5 Microbiota Transplantation Service Market by Application
  1. 5.1 Microbiota Transplantation Service Application Introduction
  2. 5.1.1 Medical Industry
  3. 5.1.2 Health Management Industry
  4. 5.1.3 Animal Health Industry
  5. 5.1.4 Others
  6. 5.2 Global Microbiota Transplantation Service Sales Value by Application
  7. 5.2.1 Global Microbiota Transplantation Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Microbiota Transplantation Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Microbiota Transplantation Service Sales Value Share by Application (2021-2032)
6 Microbiota Transplantation Service Regional Value Analysis
  1. 6.1 Global Microbiota Transplantation Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbiota Transplantation Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microbiota Transplantation Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microbiota Transplantation Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbiota Transplantation Service Sales Value (2021-2032)
  7. 6.3.2 North America Microbiota Transplantation Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microbiota Transplantation Service Sales Value (2021-2032)
  10. 6.4.2 Europe Microbiota Transplantation Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microbiota Transplantation Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microbiota Transplantation Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microbiota Transplantation Service Sales Value (2021-2032)
  16. 6.6.2 South America Microbiota Transplantation Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microbiota Transplantation Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microbiota Transplantation Service Sales Value Share by Country, 2025 VS 2032
7 Microbiota Transplantation Service Country-level Value Analysis
  1. 7.1 Global Microbiota Transplantation Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microbiota Transplantation Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microbiota Transplantation Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microbiota Transplantation Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microbiota Transplantation Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microbiota Transplantation Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microbiota Transplantation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Seres Therapeutics
  2. 8.1.1 Seres Therapeutics Company Information
  3. 8.1.2 Seres Therapeutics Business Overview
  4. 8.1.3 Seres Therapeutics Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Seres Therapeutics Microbiota Transplantation Service Product Portfolio
  6. 8.1.5 Seres Therapeutics Recent Developments
  7. 8.2 Finch Therapeutics
  8. 8.2.1 Finch Therapeutics Company Information
  9. 8.2.2 Finch Therapeutics Business Overview
  10. 8.2.3 Finch Therapeutics Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Finch Therapeutics Microbiota Transplantation Service Product Portfolio
  12. 8.2.5 Finch Therapeutics Recent Developments
  13. 8.3 OpenBiome
  14. 8.3.1 OpenBiome Company Information
  15. 8.3.2 OpenBiome Business Overview
  16. 8.3.3 OpenBiome Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 OpenBiome Microbiota Transplantation Service Product Portfolio
  18. 8.3.5 OpenBiome Recent Developments
  19. 8.4 Vedanta Biosciences
  20. 8.4.1 Vedanta Biosciences Company Information
  21. 8.4.2 Vedanta Biosciences Business Overview
  22. 8.4.3 Vedanta Biosciences Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vedanta Biosciences Microbiota Transplantation Service Product Portfolio
  24. 8.4.5 Vedanta Biosciences Recent Developments
  25. 8.5 MaaT Pharma
  26. 8.5.1 MaaT Pharma Company Information
  27. 8.5.2 MaaT Pharma Business Overview
  28. 8.5.3 MaaT Pharma Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MaaT Pharma Microbiota Transplantation Service Product Portfolio
  30. 8.5.5 MaaT Pharma Recent Developments
  31. 8.6 BiomX
  32. 8.6.1 BiomX Company Information
  33. 8.6.2 BiomX Business Overview
  34. 8.6.3 BiomX Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BiomX Microbiota Transplantation Service Product Portfolio
  36. 8.6.5 BiomX Recent Developments
  37. 8.7 Entera Health
  38. 8.7.1 Entera Health Company Information
  39. 8.7.2 Entera Health Business Overview
  40. 8.7.3 Entera Health Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Entera Health Microbiota Transplantation Service Product Portfolio
  42. 8.7.5 Entera Health Recent Developments
  43. 8.8 Metabiomics
  44. 8.8.1 Metabiomics Company Information
  45. 8.8.2 Metabiomics Business Overview
  46. 8.8.3 Metabiomics Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Metabiomics Microbiota Transplantation Service Product Portfolio
  48. 8.8.5 Metabiomics Recent Developments
  49. 8.9 J-Pharma
  50. 8.9.1 J-Pharma Company Information
  51. 8.9.2 J-Pharma Business Overview
  52. 8.9.3 J-Pharma Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 J-Pharma Microbiota Transplantation Service Product Portfolio
  54. 8.9.5 J-Pharma Recent Developments
  55. 8.10 Hangzhou Shengshi Technology
  56. 8.10.1 Hangzhou Shengshi Technology Company Information
  57. 8.10.2 Hangzhou Shengshi Technology Business Overview
  58. 8.10.3 Hangzhou Shengshi Technology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Shengshi Technology Microbiota Transplantation Service Product Portfolio
  60. 8.10.5 Hangzhou Shengshi Technology Recent Developments
  61. 8.11 Ruiyi Biotechnology
  62. 8.11.1 Ruiyi Biotechnology Company Information
  63. 8.11.2 Ruiyi Biotechnology Business Overview
  64. 8.11.3 Ruiyi Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ruiyi Biotechnology Microbiota Transplantation Service Product Portfolio
  66. 8.11.5 Ruiyi Biotechnology Recent Developments
  67. 8.12 Jiangsu Junkey Life Technology Development
  68. 8.12.1 Jiangsu Junkey Life Technology Development Company Information
  69. 8.12.2 Jiangsu Junkey Life Technology Development Business Overview
  70. 8.12.3 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Product Portfolio
  72. 8.12.5 Jiangsu Junkey Life Technology Development Recent Developments
  73. 8.13 Hangzhou Yuanxiang Medical Technology
  74. 8.13.1 Hangzhou Yuanxiang Medical Technology Company Information
  75. 8.13.2 Hangzhou Yuanxiang Medical Technology Business Overview
  76. 8.13.3 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Product Portfolio
  78. 8.13.5 Hangzhou Yuanxiang Medical Technology Recent Developments
  79. 8.14 MAUSOAR
  80. 8.14.1 MAUSOAR Company Information
  81. 8.14.2 MAUSOAR Business Overview
  82. 8.14.3 MAUSOAR Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MAUSOAR Microbiota Transplantation Service Product Portfolio
  84. 8.14.5 MAUSOAR Recent Developments
  85. 8.15 Shanghai Chengge Biotechnology
  86. 8.15.1 Shanghai Chengge Biotechnology Company Information
  87. 8.15.2 Shanghai Chengge Biotechnology Business Overview
  88. 8.15.3 Shanghai Chengge Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shanghai Chengge Biotechnology Microbiota Transplantation Service Product Portfolio
  90. 8.15.5 Shanghai Chengge Biotechnology Recent Developments
  91. 8.16 Guangzhou Zhiyi Biotechnology
  92. 8.16.1 Guangzhou Zhiyi Biotechnology Company Information
  93. 8.16.2 Guangzhou Zhiyi Biotechnology Business Overview
  94. 8.16.3 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Product Portfolio
  96. 8.16.5 Guangzhou Zhiyi Biotechnology Recent Developments
  97. 8.17 Shenzhen Unknown Jun Biotechnology
  98. 8.17.1 Shenzhen Unknown Jun Biotechnology Company Information
  99. 8.17.2 Shenzhen Unknown Jun Biotechnology Business Overview
  100. 8.17.3 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Product Portfolio
  102. 8.17.5 Shenzhen Unknown Jun Biotechnology Recent Developments
  103. 8.18 Sichuan Anaerobic Biotechnology
  104. 8.18.1 Sichuan Anaerobic Biotechnology Company Information
  105. 8.18.2 Sichuan Anaerobic Biotechnology Business Overview
  106. 8.18.3 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Product Portfolio
  108. 8.18.5 Sichuan Anaerobic Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst